George, Remicade (one of the first, if not the first immunologic), Humira and about 8 or 9 others have varying degrees of success and varying degrees of contraindications in the IBD-psoriasis-psoriatic arthritis-Crohn's continuum. And they all lose their effects over time, though not necessarily all their side effects. The difference is that they all have gone through an FDA 3 successfully. And IPIX has not. An oral compound with no/few debilitating side-effects that worked, even modestly, would be a hit. And if it did not cost $900 for less than 30 pills that would be a good thing for patients, insurers, hospital formularies,and even IPIX, though not necessarily for its competitors.
News 
Market Data 
Discover 
